Evidence map›Paper›PMID 30176799›Full record

ArticleBMC cardiovascular disorders2018

Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study.

Jorge Navarro-Pérez, Domingo Orozco-Beltran, Vicente Gil-Guillen, Vicente Pallares, Francisco Valls, Antonio Fernandez, Ana María Perez-Navarro, Carlos Sanchis, Alejandro Dominguez-Lucas, Jose M Martin-Moreno and 3 more

Abstract read
In one paragraph

Article in BMC cardiovascular disorders, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Tight and early HbAFrontiers in public health · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jorge Navarro-PérezBiomedical Research Institute INCLIVA, Hospital Clinico Universitario de Valencia, University of Valencia, Valencia, Spain.
Domingo Orozco-BeltranDepartment of Clinical Medicine, University Miguel Hernandez of San Juan de Alicante, San Juan de Alicante, Spain.
Vicente Gil-GuillenDepartment of Clinical Medicine, University Miguel Hernandez of San Juan de Alicante, San Juan de Alicante, Spain.
Vicente PallaresDepartment of Medicine, University Jaume I of Castellón, Unión de Mutuas de Castellón, Castellón de la Plana, Spain.
Francisco VallsHealth Center of Beniganim, Valencia. HTA Working Group SEMERGEN, Valencia, Spain.
Antonio FernandezEscarval Project, Valencia, Spain.
Ana María Perez-NavarroEscarval Project, Valencia, Spain.
Carlos SanchisCentro de Salud Algemesi, Algemesí, Spain.
Alejandro Dominguez-LucasBiomedical Research Institute INCLIVA, Hospital Clinico Universitario de Valencia, University of Valencia, Valencia, Spain.
Jose M Martin-MorenoDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, Valencia, Spain.
Josep RedonBiomedical Research Institute INCLIVA, Hospital Clinico Universitario de Valencia, University of Valencia, Valencia, Spain. josep.redon@uv.es.ORCID 0000-0001-8777-6773
Maria Tellez-PlazaBiomedical Research Institute INCLIVA, Hospital Clinico Universitario de Valencia, University of Valencia, Valencia, Spain.
ESCARVAL STUDY GROUP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite the epidemiological evidence about the relationship between diabetes, mortality and cardiovascular disease, information about the population impact of uncontrolled diabetes is scarce. We aimed to estimate the attributable risk associated with HbA1c levels for all-cause mortality and cardiovascular hospitalization.

methodsProspective study of subjects with diabetes mellitus using electronic health records from the universal public health system in the Valencian Community, Spain 2008-2012. We included 19,140 men and women aged 30 years or older with diabetes who underwent routine health examinations in primary care.

resultsA total of 11,003 (57%) patients had uncontrolled diabetes defined as HbA1c ≥6.5%, and, among those, 5325 participants had HbA1c ≥7.5%. During an average follow-up time of 3.3 years, 499 deaths, 912 hospitalizations for coronary heart disease (CHD) and 786 hospitalizations for stroke were recorded. We observed a linear and increasingly positive dose-response of HbA1c levels and CHD hospitalization. The relative risk for all-cause mortality and CHD and stroke hospitalization comparing patients with and without uncontrolled diabetes was 1.29 (95 CI 1.08,1.55), 1.38 (95 CI 1.20,1.59) and 1.05 (95 CI 0.91, 1.21), respectively. The population attributable risk (PAR) associated with uncontrolled diabetes was 13.6% (95% CI; 4.0-23.9) for all-cause mortality, 17.9% (95% CI; 10.5-25.2) for CHD and 2.7% (95% CI; - 5.5-10.8) for stroke hospitalization.

conclusionsIn a large general-practice cohort of patients with diabetes, uncontrolled glucose levels were associated with a substantial mortality and cardiovascular disease burden.

Indexed as

AdultAgedBiomarkersCardiovascular DiseasesCause of DeathDiabetes MellitusElectronic Health RecordsFemaleGlycated HemoglobinHumansHypoglycemic AgentsMaleMiddle AgedPatient AdmissionPrimary Health CarePrognosisBiomarkersGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsAll-cause mortalityAttributable riskCoronary heart diseaseDiabetesHbA1cHospitalizationStroke

Identifiers

PMID30176799
PMCPMC6122181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.